All In Biotech

Drug Trial Radar · NCT03701334

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)

Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 5,101 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

5,101

Actual

Start

Dec 7, 2018

Primary completion

May 29, 2030

Study completion May 29, 2030

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
Collaborators
Translational Research in Oncology
First posted
Oct 10, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase III, multicenter, randomized, open-label trial to evaluate the efficacy and safety of ribociclib with Endocrine Therapy (ET) as an adjuvant treatment in women and men with Hormone Receptor positive (HR+), Human Epidermal Growth Factor Receptor 2 negative (HER2-) Early Breast Cancer (EBC).

Conditions

  • Early Breast Cancer

Interventions

  • RibociclibDrug

    Ribociclib orally taken at 400 mg on days 1 to 21 of a 28-day cycle

  • Endocrine Therapy (ET)Other

    Endocrine Therapy (ET) will be administered according to the local clinical guidelines and current local prescribing information

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Invasive Disease-Free Survival (iDFS)Time frame: Up to approximately 139 months

Locations

387 sites in 20 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham-Kirklin Clinic

    Birmingham, Alabama

  • Cancer Treatment Centers of America

    Goodyear, Arizona

  • St Bernards Medical Center

    Jonesboro, Arkansas

  • Comprehensive Blood and Cancer

    Bakersfield, California

  • UCLA Beverly Hills

    Beverly Hills, California

  • UCLA Burbank

    Burbank, California

  • Encino Research Center

    Encino, California

  • St. Jude Heritage Medical Group

    Fullerton, California

  • UCLA Hematology Oncology

    Laguna Hills, California

  • Southern CA Oncology Rsrch Alliance

    Los Angeles, California

  • Stanford University Medical Center

    Palo Alto, California

  • UCLA Pasadena HC Hemato Onco

    Pasadena, California

  • UCLA Porter Ranch Hemato and Onco

    Porter Ranch, California

  • Cancer Care Associates Medical Grp

    Redondo Beach, California

  • Sharp Memorial Hospital

    San Diego, California

  • UCSF

    San Francisco, California

  • Central Coast Medical Oncology Corporation

    Santa Maria, California

  • UCLA Santa Monica Hematology Oncology

    Santa Monica, California

  • Lundquist Inst BioMed at Harbor

    Torrance, California

  • UCLA Valencia

    Valencia, California

  • Valley Breast Care

    Van Nuys, California

  • UCLA Cancer Center Westlake Village

    Westlake Village, California

  • University Of Colorado Hospital

    Aurora, Colorado

  • Rocky Mountain Cancer Centers

    Denver, Colorado

  • Hospital of Central Connecticut

    New Britain, Connecticut

  • Yale University School Of Medicine

    New Haven, Connecticut

  • Norwalk Hospital

    Norwalk, Connecticut

  • Eastern Connecticut Hematology and Oncology Associates

    Norwich, Connecticut

  • Holy Cross Hospital-Ft. Lauderdale

    Fort Lauderdale, Florida

  • Florida Cancer Specialists

    Fort Myers, Florida

  • Memorial Cancer Institute

    Hollywood, Florida

  • Baptist MD Anderson Cancer Center

    Jacksonville, Florida

  • University of Miami

    Miami, Florida

  • Orlando Health Clinical Trials

    Orlando, Florida

  • Florida Cancer Specialists-North

    St. Petersburg, Florida

  • Florida Cancer Specialists Pan

    Tallahassee, Florida

  • Florida Cancer Specialists

    West Palm Beach, Florida

  • Winship Cancer Institute of Emory University

    Atlanta, Georgia

  • Southeastern Regional Medical Center

    Newnan, Georgia

  • Cancer Treatment Centers of America

    Zion, Illinois

Showing 40 of 387 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.